https://www.selleckchem.com/products/PI-103.html
Patients with severe aortic stenosis (AS) often present with multiple comorbidities and suffer from critical coronary artery disease (CAD). Transcatheter aortic valve replacement (TAVR) has become the therapy of choice for moderate to high-risk patients. Venoarterial extracorporeal membrane oxygenation (v-a-ECMO) offers the possibility of temporary cardiac support to manage life-threatening critical situations. Here, we describe the management of a patient with severe AS and CAD with impaired left ventricular ejection fraction (LVEF). We